IN2013MU01151A - - Google Patents
Info
- Publication number
- IN2013MU01151A IN2013MU01151A IN1151MU2013A IN2013MU01151A IN 2013MU01151 A IN2013MU01151 A IN 2013MU01151A IN 1151MU2013 A IN1151MU2013 A IN 1151MU2013A IN 2013MU01151 A IN2013MU01151 A IN 2013MU01151A
- Authority
- IN
- India
- Prior art keywords
- mcc
- lactose
- pharmaceutical composition
- relates
- present
- Prior art date
Links
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 3
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 3
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 2
- 239000008101 lactose Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000000735 allogeneic effect Effects 0.000 abstract 1
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical group OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 abstract 1
- 229960000951 mycophenolic acid Drugs 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to process for preparation of a pharmaceutical composition of mycophenolic acid or salts thereof. In particular, the present invention relates to a process of preparing the pharmaceutical composition comprising use of lactose and microcrystalline cellulose (MCC) in the ratio of amount of lactose to MCC is in the range of about 1.0:6.0 to about 6.0: 1.0. The invention also includes use of composition prepared by such processes in the prophylaxis of organ rejection in patients receiving allogeneic renal transplants.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1151MU2013 IN2013MU01151A (en) | 2013-03-26 | 2014-03-24 | |
| PCT/IB2014/060080 WO2014167442A1 (en) | 2013-03-26 | 2014-03-24 | Pharmaceutical compositions comprising mycophenolic acid or salts thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1151MU2013 IN2013MU01151A (en) | 2013-03-26 | 2014-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01151A true IN2013MU01151A (en) | 2015-04-24 |
Family
ID=54395421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1151MU2013 IN2013MU01151A (en) | 2013-03-26 | 2014-03-24 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01151A (en) |
-
2014
- 2014-03-24 IN IN1151MU2013 patent/IN2013MU01151A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX2015012414A (en) | Salt of omecamtiv mecarbil and process for preparing salt. | |
| IN2015KN00262A (en) | ||
| SG10201804817TA (en) | Delayed release compositions of linaclotide | |
| EA201891861A1 (en) | 2- (MORFOLIN-4-IL) -1,7-NAFTYRIDINES | |
| PH12013502549B1 (en) | Fused benzoxazepinones as ion channel modulators | |
| PH12014502041A1 (en) | Heterocyclyl compounds as mek inhibitors | |
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| EP3626253A3 (en) | Stable formulations of linaclotide | |
| MX2015004947A (en) | Multicomponent crystalline system comprising nilotinib and selected co-crystal formers. | |
| EA201600434A1 (en) | APPLICATION OF DERIVATIVES OF BENZIMIDAZOLPROLINE | |
| EA201490395A1 (en) | METHOD FOR OBTAINING PHARMACEUTICAL COMPOSITIONS CONTAINING FINGOLIMOD | |
| MX2016000163A (en) | Substituted pyrazolo-pyridinamines. | |
| MX2015009617A (en) | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoq uinoline-3-carbonyl]-amino}-acetic acid. | |
| MX2016001422A (en) | Pharmaceutical compositions of fingolimod. | |
| PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| MX2022005766A (en) | Compounds and methods of preparing compounds s1p1 modulators. | |
| UA113693C2 (en) | TITANIUM CONTENT, METHOD OF OBTAINING TITANIUM COMPOUND AND USING TITANIUM COMPOUND IN PLANT CULTIVATION | |
| MX2014009933A (en) | Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv). | |
| IN2013MU01151A (en) | ||
| IN2013MU01153A (en) | ||
| WO2011104555A3 (en) | Process for the preparation of sunitinib malate form i | |
| MX2017005080A (en) | Preparation of zinc citrate and of zinc citrate-containing oral care compositions. | |
| EA202090397A1 (en) | Fluoropiperidine Compounds as Pure 5-HT Receptor Antagonists |